US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist
  • 105.360
  • -4.770-4.33%
Close Nov 6 16:00 ET
  • 105.800
  • +0.440+0.42%
Post 20:01 ET
469.50BMarket Cap34.54P/E (TTM)

Novo-Nordisk A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.04%43.85B
76.73%50.5B
-51.99%14.31B
38.06%108.91B
34.50%9.55B
69.01%40.97B
19.26%28.58B
26.41%29.81B
43.43%78.89B
335.37%7.1B
Net income from continuing operations
21.46%27.3B
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
Operating gains losses
----
----
----
66.39%32.27B
----
----
----
----
19.23%19.39B
----
Depreciation and amortization
-14.85%2.15B
306.29%8.85B
69.52%2.91B
27.86%9.41B
47.03%2.99B
23.71%2.53B
33.07%2.18B
4.18%1.72B
22.19%7.36B
-2.26%2.04B
Deferred tax
26.82%7.08B
9.45%5.28B
32.26%6.51B
55.06%20.99B
107.67%5.66B
53.98%5.59B
38.80%4.83B
32.73%4.92B
19.55%13.54B
22.65%2.72B
Other non cash items
846.75%18.81B
4.43%11.18B
-99.42%118M
-247.68%-2.04B
-27.91%-34.96B
-88.24%1.99B
142.36%10.71B
173.82%20.23B
135.43%1.38B
-47.44%-27.33B
Change In working capital
-196.52%-11.26B
326.67%9.1B
13.35%-8.85B
-129.48%-12.25B
-3,043.83%-9.68B
205.99%11.67B
-198.19%-4.02B
-639.67%-10.22B
41.12%-5.34B
97.22%-308M
-Change in receivables
----
----
----
-49.50%-16.27B
----
----
----
----
21.04%-10.89B
----
-Change in inventory
----
----
----
-55.72%-7.42B
----
----
----
----
-339.35%-4.77B
----
-Change in payables and accrued expense
----
----
----
47.32%7.59B
----
----
----
----
64.12%5.15B
----
-Change in other current liabilities
----
----
----
27.28%5.1B
----
----
----
----
54.37%4.01B
----
-Change in other working capital
----
----
----
-206.47%-1.24B
----
----
----
----
1,467.57%1.16B
----
Cash from discontinued investing activities
Operating cash flow
7.04%43.85B
76.73%50.5B
-51.99%14.31B
38.06%108.91B
34.50%9.55B
69.01%40.97B
19.26%28.58B
26.41%29.81B
43.43%78.89B
335.37%7.1B
Investing cash flow
Cash flow from continuing investing activities
-57.85%-20.9B
-123.27%-20.73B
159.52%3.96B
-76.15%-43.89B
-6.26%-14.72B
-166.94%-13.24B
-121.07%-9.29B
-248.56%-6.65B
21.16%-24.92B
32.78%-13.85B
Net PPE purchase and sale
-107.93%-12.12B
-78.12%-10.47B
-80.57%-8.47B
-112.47%-25.81B
-89.62%-9.41B
-80.43%-5.83B
-141.40%-5.88B
-208.75%-4.69B
-91.73%-12.15B
-142.12%-4.96B
Net intangibles purchase and sale
91.97%-385M
-139.24%-2.77B
-395.37%-535M
-402.11%-13.09B
-479.95%-7.03B
-382.01%-4.8B
-726.43%-1.16B
58.46%-108M
-148.29%-2.61B
-357.36%-1.21B
Net business purchase and sale
--0
----
----
--0
--0
--0
----
----
61.30%-7.08B
----
Net investment purchase and sale
-220.77%-8.4B
-203.33%-6.83B
802.33%12.97B
-61.68%-5B
385.55%1.72B
-255.84%-2.62B
-38.46%-2.25B
-1,353.54%-1.85B
47.99%-3.09B
-9,933.33%-602M
Cash from discontinued investing activities
Investing cash flow
-57.85%-20.9B
-123.27%-20.73B
159.52%3.96B
-76.15%-43.89B
-6.26%-14.72B
-166.94%-13.24B
-121.07%-9.29B
-248.56%-6.65B
21.16%-24.92B
32.78%-13.85B
Financing cash flow
Cash flow from continuing financing activities
7.22%-18.4B
232.52%16.68B
-27.94%-26.38B
-21.93%-63.16B
-31.92%-10.12B
-36.18%-19.83B
-20.69%-12.59B
-7.77%-20.62B
-103.18%-51.8B
-268.56%-7.67B
Net issuance payments of debt
-58.24%-413M
7,998.12%29.46B
33.68%-317M
39.08%-1.47B
-175.19%-355M
20.91%-261M
-52.87%-373M
71.96%-478M
-115.56%-2.41B
-101.07%-129M
Net common stock issuance
60.84%-2.41B
15.57%-7.45B
45.45%-2.84B
-24.24%-29.92B
-29.47%-9.76B
-32.92%-6.14B
-18.43%-8.82B
-16.13%-5.2B
-23.85%-24.09B
-0.36%-7.54B
Cash dividends paid
-16.03%-15.58B
--0
-55.73%-28.56B
-25.55%-31.77B
--0
-39.71%-13.43B
--0
-16.87%-18.34B
-17.60%-25.3B
--0
Net other financing activities
----
----
57.03%5.33B
----
----
----
----
23.97%3.39B
----
----
Cash from discontinued financing activities
Financing cash flow
7.22%-18.4B
232.52%16.68B
-27.94%-26.38B
-21.93%-63.16B
-31.92%-10.12B
-36.18%-19.83B
-20.69%-12.59B
-7.77%-20.62B
-103.18%-51.8B
-268.56%-7.67B
Net cash flow
Beginning cash position
144.84%52.82B
-57.66%6.32B
13.74%14.39B
18.04%12.65B
7.05%29.88B
-5.19%21.57B
13.08%14.94B
18.04%12.65B
-12.33%10.72B
-5.34%27.91B
Current changes in cash
-42.40%4.55B
593.05%46.46B
-418.62%-8.11B
-14.46%1.86B
-6.00%-15.28B
67.36%7.89B
-28.16%6.7B
0.08%2.55B
203.53%2.17B
24.40%-14.42B
Effect of exchange rate changes
-183.25%-348M
164.62%42M
116.73%44M
50.00%-119M
75.24%-209M
-5.64%418M
-129.82%-65M
-378.18%-263M
-140.27%-238M
-381.33%-844M
End cash Position
90.80%57.02B
144.84%52.82B
-57.66%6.32B
13.74%14.39B
13.74%14.39B
7.05%29.88B
-5.19%21.57B
13.08%14.94B
18.04%12.65B
18.04%12.65B
Free cash flow
3.31%31.35B
72.99%37.27B
-78.79%5.31B
9.17%70.01B
-841.92%-6.89B
51.60%30.34B
0.73%21.54B
14.71%25.01B
34.69%64.13B
117.41%928M
Currency Unit
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.04%43.85B 76.73%50.5B -51.99%14.31B 38.06%108.91B 34.50%9.55B 69.01%40.97B 19.26%28.58B 26.41%29.81B 43.43%78.89B 335.37%7.1B
Net income from continuing operations 21.46%27.3B 3.20%20.05B 28.23%25.41B 50.71%83.68B 61.59%21.96B 56.04%22.48B 45.88%19.43B 39.44%19.81B 16.27%55.53B 24.79%13.59B
Operating gains losses ---- ---- ---- 66.39%32.27B ---- ---- ---- ---- 19.23%19.39B ----
Depreciation and amortization -14.85%2.15B 306.29%8.85B 69.52%2.91B 27.86%9.41B 47.03%2.99B 23.71%2.53B 33.07%2.18B 4.18%1.72B 22.19%7.36B -2.26%2.04B
Deferred tax 26.82%7.08B 9.45%5.28B 32.26%6.51B 55.06%20.99B 107.67%5.66B 53.98%5.59B 38.80%4.83B 32.73%4.92B 19.55%13.54B 22.65%2.72B
Other non cash items 846.75%18.81B 4.43%11.18B -99.42%118M -247.68%-2.04B -27.91%-34.96B -88.24%1.99B 142.36%10.71B 173.82%20.23B 135.43%1.38B -47.44%-27.33B
Change In working capital -196.52%-11.26B 326.67%9.1B 13.35%-8.85B -129.48%-12.25B -3,043.83%-9.68B 205.99%11.67B -198.19%-4.02B -639.67%-10.22B 41.12%-5.34B 97.22%-308M
-Change in receivables ---- ---- ---- -49.50%-16.27B ---- ---- ---- ---- 21.04%-10.89B ----
-Change in inventory ---- ---- ---- -55.72%-7.42B ---- ---- ---- ---- -339.35%-4.77B ----
-Change in payables and accrued expense ---- ---- ---- 47.32%7.59B ---- ---- ---- ---- 64.12%5.15B ----
-Change in other current liabilities ---- ---- ---- 27.28%5.1B ---- ---- ---- ---- 54.37%4.01B ----
-Change in other working capital ---- ---- ---- -206.47%-1.24B ---- ---- ---- ---- 1,467.57%1.16B ----
Cash from discontinued investing activities
Operating cash flow 7.04%43.85B 76.73%50.5B -51.99%14.31B 38.06%108.91B 34.50%9.55B 69.01%40.97B 19.26%28.58B 26.41%29.81B 43.43%78.89B 335.37%7.1B
Investing cash flow
Cash flow from continuing investing activities -57.85%-20.9B -123.27%-20.73B 159.52%3.96B -76.15%-43.89B -6.26%-14.72B -166.94%-13.24B -121.07%-9.29B -248.56%-6.65B 21.16%-24.92B 32.78%-13.85B
Net PPE purchase and sale -107.93%-12.12B -78.12%-10.47B -80.57%-8.47B -112.47%-25.81B -89.62%-9.41B -80.43%-5.83B -141.40%-5.88B -208.75%-4.69B -91.73%-12.15B -142.12%-4.96B
Net intangibles purchase and sale 91.97%-385M -139.24%-2.77B -395.37%-535M -402.11%-13.09B -479.95%-7.03B -382.01%-4.8B -726.43%-1.16B 58.46%-108M -148.29%-2.61B -357.36%-1.21B
Net business purchase and sale --0 ---- ---- --0 --0 --0 ---- ---- 61.30%-7.08B ----
Net investment purchase and sale -220.77%-8.4B -203.33%-6.83B 802.33%12.97B -61.68%-5B 385.55%1.72B -255.84%-2.62B -38.46%-2.25B -1,353.54%-1.85B 47.99%-3.09B -9,933.33%-602M
Cash from discontinued investing activities
Investing cash flow -57.85%-20.9B -123.27%-20.73B 159.52%3.96B -76.15%-43.89B -6.26%-14.72B -166.94%-13.24B -121.07%-9.29B -248.56%-6.65B 21.16%-24.92B 32.78%-13.85B
Financing cash flow
Cash flow from continuing financing activities 7.22%-18.4B 232.52%16.68B -27.94%-26.38B -21.93%-63.16B -31.92%-10.12B -36.18%-19.83B -20.69%-12.59B -7.77%-20.62B -103.18%-51.8B -268.56%-7.67B
Net issuance payments of debt -58.24%-413M 7,998.12%29.46B 33.68%-317M 39.08%-1.47B -175.19%-355M 20.91%-261M -52.87%-373M 71.96%-478M -115.56%-2.41B -101.07%-129M
Net common stock issuance 60.84%-2.41B 15.57%-7.45B 45.45%-2.84B -24.24%-29.92B -29.47%-9.76B -32.92%-6.14B -18.43%-8.82B -16.13%-5.2B -23.85%-24.09B -0.36%-7.54B
Cash dividends paid -16.03%-15.58B --0 -55.73%-28.56B -25.55%-31.77B --0 -39.71%-13.43B --0 -16.87%-18.34B -17.60%-25.3B --0
Net other financing activities ---- ---- 57.03%5.33B ---- ---- ---- ---- 23.97%3.39B ---- ----
Cash from discontinued financing activities
Financing cash flow 7.22%-18.4B 232.52%16.68B -27.94%-26.38B -21.93%-63.16B -31.92%-10.12B -36.18%-19.83B -20.69%-12.59B -7.77%-20.62B -103.18%-51.8B -268.56%-7.67B
Net cash flow
Beginning cash position 144.84%52.82B -57.66%6.32B 13.74%14.39B 18.04%12.65B 7.05%29.88B -5.19%21.57B 13.08%14.94B 18.04%12.65B -12.33%10.72B -5.34%27.91B
Current changes in cash -42.40%4.55B 593.05%46.46B -418.62%-8.11B -14.46%1.86B -6.00%-15.28B 67.36%7.89B -28.16%6.7B 0.08%2.55B 203.53%2.17B 24.40%-14.42B
Effect of exchange rate changes -183.25%-348M 164.62%42M 116.73%44M 50.00%-119M 75.24%-209M -5.64%418M -129.82%-65M -378.18%-263M -140.27%-238M -381.33%-844M
End cash Position 90.80%57.02B 144.84%52.82B -57.66%6.32B 13.74%14.39B 13.74%14.39B 7.05%29.88B -5.19%21.57B 13.08%14.94B 18.04%12.65B 18.04%12.65B
Free cash flow 3.31%31.35B 72.99%37.27B -78.79%5.31B 9.17%70.01B -841.92%-6.89B 51.60%30.34B 0.73%21.54B 14.71%25.01B 34.69%64.13B 117.41%928M
Currency Unit DKK DKK DKK DKK DKK DKK DKK DKK DKK DKK
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- Unqualified Opinion with Explanatory Notes --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Weight Loss Drugs
Weight Loss Drugs
Intraday-3.23%